Cost -- Student: $15 | Member: $35 | Non-member: $65
Appearing in both medical journals and pop culture magazines, psychedelic medicines are making a comeback. For the first time since the Hippie Generation, consciousness-altering substances like LSD (“acid”) and psilocybin (“magic mushrooms”) are being studied as novel breakthrough therapies for a host of mental health conditions – including treatment-resistant depression, anxiety, addiction, and more. In this talk, the third in our Psychedelics mini-series, we will explore the emerging clinical data on these substances and consider their unique properties as powerful adjuvants to psychotherapeutic counseling. The basic (known) pharmacology of common psychedelics will be reviewed and their proposed mechanisms of action explained. As with every presentation given by Dr. Zelfand, this one promises to be engaging, funny, packed with evidence-based information, and entirely off-the-beaten-track.
Speaker Bio: Erica Zelfand, ND is an integrative family physician, medical journalist, teacher, and international speaker. She is deeply committed to patient-centered, root-cause-oriented, nature-honoring approaches to healing. After graduating from NUNM with high honors and completing an accredited residency in family medicine, Dr. Zelfand pursued additional post doctorate training in pediatrics. She is one of the first physicians in the country to enroll in above-board training in MDMA-assisted therapy through the Multidisciplinary Association for Psychedelic Studies (MAPS). She is also a volunteer “trip sitter,” medical lead, and psychedelic harm reduction workshop co-facilitator. She is also the mastermind behind a multi-modular training in psychedelic therapeutics for healthcare providers. Dr. Zelfand loves sharing her knowledge, her reverence for nature, and her zesty sense of humor with colleagues, clients, and audiences of all sizes worldwide. To learn more and connect, please visit www.DrZelfand.com.
*Certified by the WANP for 1 Category 1 continuing education credit (including 1 Pharmacology credit) for Washington NDs*
(Originally presented on October 12, 2020)